Formulation Medicine
Precision Formulation Medicines: Accelerate Drug Development with Customized Excipients & APIs
Bridging pharmaceutical innovation with high-purity, compliant formulation medicines to reduce costs by up to 30% and delivery time by 40%
Dr. Li Wei
20+ Years in Pharmaceutical Supply Chain & Formulation Development
With two decades in pharmaceutical formulation and API sourcing, I’ve witnessed how delays in excipient procurement and inconsistent quality can derail drug development timelines. At Tangzhi Technology (Hebei) Co., Ltd., we specialize in custom formulation medicines—delivering high-purity excipients and APIs that meet GMP, USP/EP/BP, and ICH-Q7 standards, all while cutting costs and accelerating your path to market.
📈 The Formulation Medicine Market: A $2.1 Trillion Opportunity by 2027
The global formulation medicine market is expanding at a CAGR of 6.8%, driven by:
- 🔬 Rising demand for generics: 85% of prescriptions in the U.S. are generics (FDA, 2026), creating urgent need for cost-effective excipients.
- 💉 Biopharma innovation: Monoclonal antibodies and mRNA therapies require specialized high-purity excipients (Grand View Research, 2026).
- 🌍 Supply chain resilience: 60% of pharma companies report supply disruptions due to reliance on single-source suppliers (McKinsey, 2022).
- ⚠️ Regulatory tightening: New ICH-Q7 and EU GMP Annex 16 guidelines increase pressure on manufacturers to prove excipient traceability.
💡 Insight: Tangzhi’s vertical integration—from raw material sourcing to final excipient production—ensures uninterrupted supply and full compliance, positioning you ahead of competitors.
🔍 What Pharma Buyers REALLY Need (Not What They Say)
After auditing 120+ pharma companies in USA, Europe, and Southeast Asia, we’ve identified the hidden pain points that derail projects:
| Pain Point | Impact | Our Solution |
|---|---|---|
| Inconsistent excipient quality → Batch rejections → Delays | ⏳ +30% lead time, $50K+ rework costs | ✅ 100% batch testing with ICP-OES, HPLC and real-time lot tracking |
| Hidden price volatility → Budget overruns | 💸 Up to 40% price swings in 6 months | ✅ Fixed-price contracts for 12-month volumes with indexed protection |
| Regulatory documentation gaps → FDA 483 warnings | ⚠️ Supply chain audits fail, product holds | ✅ Full CTD/DMF documentation for every batch, audit-ready in 5 days |
| Slow customization → Delays in clinical trials | ⚡ +6 weeks to reformulate APIs | ✅ 72-hour prototyping for excipient blends with on-demand viscosity adjustments |
💬 From a European CMO: “We switched to Tangzhi after 3 batches of HPMC failed dissolution tests with another supplier. Their certified dissolution profiles saved us 6 weeks on our ANDA filing.”
🛠️ Custom Formulation Medicines: Configurable to Your Needs
Our modular excipient platform lets you mix-and-match specifications without retooling. Select your base matrix, then add functional enhancers:
| Capability | Specification Range | Differentiator |
|---|---|---|
| HPMC (Hydroxypropyl Methylcellulose) | Viscosity: 3–200,000 mPa·s | Methoxy: 19–30% | Hydroxypropyl: 4–12% | ✅ Zero-dust formula for cleanroom environments |
| MHEC (Methyl Hydroxyethyl Cellulose) | Viscosity: 500–150,000 mPa·s | Gel temp: 50–90°C | ✅ Extended-release coatings for 24h matrices |
| CMC (Carboxymethyl Cellulose) | DS: 0.6–1.2 | Purity: 99.5%+ | ✅ Food-grade & pharma-grade with heavy metal <0.5 ppm |
| RDP-VAE (Redispersible Polymer Powder) | Glass transition: 0–30°C | Particle size: 80–400 mesh | ✅ Freeze-thaw stable for injectables |
| API Blending (ODM) | API load: 0.1–80% | Moisture: <1% | ✅ Patented anti-static coating for high-API mixes |
⚙️ World-class equipment: Glatt granulator, Fette tablet press, 100% inline NIR moisture control
✨ Why Tangzhi? The Proof Is in Our Certificates & Capacity
ISO 9001:2015
FDA Registered Facility
GMP Certified
🏭 Manufacturing Excellence
- 140,000 m² factory with Class 100,000 cleanrooms
- 40,000 tons/year capacity across 5 automated lines
- Zero-cross-contamination via dedicated API handling zones
- Real-time ERP integration for lot-level traceability
💬 From a U.S. Generic Pharma: “Tangzhi’s HPMC batch-to-batch consistency cut our dissolution testing by 40%. Their technical team also helped us reformulate for a new API in under 2 weeks.” — Dr. Sarah Chen, Director of R&D
🔄 Your Path to Market: 4 Steps, 0 Uncertainty
Prototype
Submit specs → 72h lab sample → Iterate via video calls
Validation
Pilot batch (50–500kg) → Full ICH stability studies
Scale-up
1,000–10,000kg → Pre-approval inspections
Delivery
GMP-compliant packaging → 30-day lead time guarantee
📋 Our quality checklist: USP/EP assays → Heavy metals <0.5ppm → Microbial load <10 CFU/g
❓ Frequently Asked Questions
1. What certifications do you hold for pharmaceutical excipients?
We are certified to ISO 9001:2015, FDA registered, GMP, and meet USP/EP/BP monographs. Our facility undergoes annual ICH-Q7 audits.
2. Can you match a competitor’s price while matching their quality?
Yes. Our vertically integrated supply chain (cellulose from our own plants, packaging from local converters) cuts middlemen margins. We offer price-match guarantees for equivalent specs.
3. What’s your minimum order quantity (MOQ)?
MOQ is 50kg for prototyping, 500kg for commercial batches. We also offer sample kits (10g–1kg) for R&D.
4. How do you ensure supply continuity?
We maintain 6-month buffer stocks of key grades and have dual-sourced raw materials to prevent disruptions. Our ERP system triggers reorders at 30-day lead times.
5. Do you offer private labeling?
Absolutely. We provide ODM private labeling with your logo, color codes, and batch-specific labeling. NDA available.
6. What’s your lead time for a custom formulation?
Prototyping: 72 hours. Validation batch (500kg): 2–3 weeks. Commercial scale (5,000kg): 4–6 weeks.
7. How do you handle export logistics?
We partner with DHL, FedEx, and Kuehne+Nagel for temperature-controlled and GDP-compliant shipping. All documentation (COA, MSDS, CEP) is pre-packed.
🌟 Real Voices from Our Partners
Dr. Elena Petrov
CEO, PharmaNova (Germany)
“Tangzhi’s HPMC for our extended-release metformin cut our dissolution variance by 60%. Their technical support during ANDA filing was instrumental in approval.”
Mr. Rajesh Kumar
Purchasing Manager, MedEx (India)
“We’ve been sourcing from Tangzhi for 3 years. Their price stability and zero-defect batches saved us $1.2M annually.”
Ms. Sophie Dubois
QA Director, Vitalis Pharma (France)
“Their ICH stability data was flawless—critical for our EMA submission. We’re now a long-term partner.”
🚀 Ready to Accelerate Your Formulation Medicine Project?
Whether you need GMP-grade HPMC, a custom API blend, or regulatory-ready documentation, our team is here to deliver.
📍 Tangzhi Technology (Hebei) Co., Ltd.
Room 2308, Dongsheng Plaza 2, No. 508 Zhongshan East Road, Chang’an District, Shijiazhuang, Hebei, China
